These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25915526)

  • 1. Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.
    Pinacho R; Saia G; Fusté M; Meléndez-Pérez I; Villalta-Gil V; Haro JM; Gill G; Ramos B
    PLoS One; 2015; 10(4):e0125115. PubMed ID: 25915526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjects.
    Pinacho R; Saia G; Meana JJ; Gill G; Ramos B
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1650-1660. PubMed ID: 26049820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis.
    Fusté M; Pinacho R; Meléndez-Pérez I; Villalmanzo N; Villalta-Gil V; Haro JM; Ramos B
    J Psychiatr Res; 2013 Nov; 47(11):1608-14. PubMed ID: 23941741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium.
    Pinacho R; Villalmanzo N; Lalonde J; Haro JM; Meana JJ; Gill G; Ramos B
    Bipolar Disord; 2011; 13(5-6):474-85. PubMed ID: 22017217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the transcription factor Sp4 is reduced by NMDA receptor signaling.
    Saia G; Lalonde J; Sun X; Ramos B; Gill G
    J Neurochem; 2014 May; 129(4):743-52. PubMed ID: 24475768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity proteins 1 and 4, hippocampal volume and first-episode psychosis.
    Fusté M; Meléndez-Pérez I; Villalta-Gil V; Pinacho R; Villalmanzo N; Cardoner N; Menchón JM; Haro JM; Soriano-Mas C; Ramos B
    Br J Psychiatry; 2016 Jun; 208(6):591-2. PubMed ID: 26541691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.
    Pinacho R; Valdizán EM; Pilar-Cuellar F; Prades R; Tarragó T; Haro JM; Ferrer I; Ramos B
    J Psychiatr Res; 2014 Nov; 58():189-96. PubMed ID: 25175639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
    Vila È; Huerta-Ramos E; Núñez C; Usall J; Ramos B
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):941-948. PubMed ID: 30167782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.
    Conus P; Berk M; Cotton SM; Kader L; Macneil C; Hasty MK; Hallam K; Lambert M; Murphy BP; McGorry PD
    Eur Psychiatry; 2015 Nov; 30(8):975-82. PubMed ID: 26485297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.
    Taraskina AE; Nasyrova RF; Zabotina AM; Sosin DN; Sosina КА; Ershov EE; Grunina MN; Krupitsky EM
    BMC Psychiatry; 2017 Dec; 17(1):394. PubMed ID: 29221470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP; Ahl J; Meyers AL; Kaiser CJ; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
    González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
    Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
    Rasmussen SA; Rosebush PI; Anglin RE; Mazurek MF
    Psychiatry Res; 2016 Jul; 241():72-7. PubMed ID: 27156027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.
    van Bruggen M; van Amelsvoort T; Wouters L; Dingemans P; de Haan L; Linszen D
    Psychoneuroendocrinology; 2009 Aug; 34(7):989-95. PubMed ID: 19264412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
    de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
    JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning.
    Sun X; Pinacho R; Saia G; Punko D; Meana JJ; Ramos B; Gill G
    Dev Neurobiol; 2015 Jan; 75(1):93-108. PubMed ID: 25045015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.